Granite Point Capital Management, L.P.

Holdings History for Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT)

Symbol: SRPT on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2019		-0.9%	$0	0	-8,000	-100%	$18.84	Q3 2019
30 Jun 2019	0.9%	-1.4%	$1,216,000	8,000	-12,500	-61%	$152.00	Q2 2019
31 Mar 2019	1.5%	0%	$2,443,000	20,500	0		$119.17	Q1 2019
31 Dec 2018	2.1%	0%	$2,237,000	20,500	0		$109.12	Q4 2018
30 Sep 2018	1.9%	-0.67%	$3,311,000	20,500	-7,220	-26%	$161.51	Q3 2018
30 Jun 2018	1.8%	-0.21%	$3,664,000	27,720	-3,300	-11%	$132.18	Q2 2018
31 Mar 2018	1.4%	-0.62%	$2,298,000	31,020	-13,200	-30%	$74.08	Q1 2018
31 Dec 2017	1.3%	-0.07%	$2,460,000	44,220	-2,300	-4.9%	$55.63	Q4 2017
30 Sep 2017	1.2%	-0.45%	$2,110,000	46,520	-16,700	-26%	$45.36	Q3 2017
30 Jun 2017	1.4%	+0.88%	$2,131,000	63,220	+39,850	+171%	$33.71	Q2 2017
31 Mar 2017	0.47%	-0.74%	$692,000	23,370	-36,630	-61%	$29.61	Q1 2017
31 Dec 2016	1.4%	-2.4%	$1,646,000	60,000	-100,000	-62%	$27.43	Q4 2016
30 Sep 2016	8.1%	+2.3%	$9,826,000	160,000	+45,000	+39%	$61.41	Q3 2016
30 Jun 2016	2%	+2%	$2,193,000	115,000	+115,000	NEW	$19.07	Q2 2016

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.